Skip to main content
. Author manuscript; available in PMC: 2015 Jan 1.
Published in final edited form as: J Hepatol. 2013 Aug 23;60(1):160–166. doi: 10.1016/j.jhep.2013.08.015

Fig. 2. Oltipraz increases hepatic GSH content and bile flow rates.

Fig. 2

(A) Bile flow rate and (B) GSH secretion rate in unoperated mice treated with CMC or oltipraz. (C) Hepatic glutathione contents of unoperated and BDL mice treated with CMC or oltipraz. * p < 0.05; between indicated groups.